Chemours posted Q3 2026 net income of $196 million, up significantly from $46 million a year earlier, supported by a 3% sales increase to $1.54 billion. Growth was led by Titanium Technologies and Advanced Performance Materials segments, with strong pricing and demand in specialty products, including AI infrastructure markets. The company settled PFAS-related litigation and completed a $340 million property sale. Looking ahead, Chemours expects Q4 sales to decline due to seasonality but anticipates adjusted EBITDA between $160 million and $185 million, with full-year 2026 sales growth of about 2%.
Chemours Company Q3 results provide context for readers. For those tracking Basic Materials, 53 of 83 US stocks rose on Pluang, while 29 fell as of Nov 03, 2026 04:11 WIB. Notable movers include GFI at USD 33.05, down 5.89%, CLMT at USD 46.80, down 5.79%, and WPM at USD 116.58, down 5.42%.
Global Indemnity Group will postpone its third quarter 2026 earnings call originally scheduled for November 4 to January, when new CEO Jessica Buss will present her vision and priorities for the company. The company will still release its Q3 results ...
Lorraine Ben, former CEO of Lockheed Martin Canada, has joined Syntax Defence to provide expert counsel amid Canada's commitment to invest over half a trillion dollars in defence over the next decade. This includes $180 billion in procurement opportu...
Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...
Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...
The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...
